Section 180-7-064 - TRAINING FOR OPHTHALMIC USE OF STRONTIUM-90Other than as provided in 180 NAC 7-026, the licensee must require the authorized user of strontium-90 for ophthalmic uses authorized under 180 NAC 7-055 to be:
(A) A physician who is an authorized user under 180 NAC 7-063 or equivalent NRC or Agreement State requirements; or(B) A physician that has: (i) Completed 24 hours of classroom and laboratory training applicable to the medical use of strontium-90 for ophthalmic radiotherapy. The training must include: (1) Radiation physics and instrumentation;(2) Radiation protection;(3) Mathematics pertaining to the use and measurement of radioactivity; and(4) Radiation biology; and(ii) Supervised clinical training in ophthalmic radiotherapy under the supervision of an authorized user at a medical institution, clinic, or private practice that includes the use of strontium-90 for the ophthalmic treatment of five individuals. This supervised clinical training must involve: (1) Examination of each individual to be treated;(2) Calculation of the dose to be administered;(3) Administration of the dose; and(4) Follow up and review of each individual's case history; and (iii) Obtained written attestation, signed by a preceptor authorized user who meets the requirements in 180 NAC 7-026, 7-063, 7-064 or equivalent NRC or Agreement State requirements, that the individual has satisfactorily completed the requirements in 180 NAC 7-064(B) and is able to independently fulfill the radiation safety-related duties as an authorized user of strontium-90 for ophthalmic use.180 Neb. Admin. Code, ch. 7, § 064
Amended effective 11/3/2020Amended effective 6/14/2023